60 related articles for article (PubMed ID: 5497621)
1. Mechanisms of drug interaction in the pharmacokinetic phase of drug activity.
Stockley IH
Am J Hosp Pharm; 1970 Dec; 27(12):977-85. PubMed ID: 5497621
[No Abstract] [Full Text] [Related]
2. Biopharmaceutics of vitamin A injection.
Bauernfeind JC; Newmark HL
Bull Parenter Drug Assoc; 1970; 24(4):169-75. PubMed ID: 5431584
[No Abstract] [Full Text] [Related]
3. [Parabolic relationship between biological activity and hydrophobicity in congenergic series: transport or protein binding?].
Franke R; Schmidt W
Acta Biol Med Ger; 1973; 31(2):273-87. PubMed ID: 4774057
[No Abstract] [Full Text] [Related]
4. [Pharmacokinetic aspects relevant to biopharmaceutics].
Segre G
Ann Ist Super Sanita; 1982; 18(3):533-40. PubMed ID: 7187841
[No Abstract] [Full Text] [Related]
5. Some considerations in the experimental approach to distinguishing between membrane transport and intracellular disposition of antineoplastic agents, with specific reference to fluorodeoxyuridine, actinomycin D, and methotrexate.
Goldman D; Bowen D; Gewirtz DA
Cancer Treat Rep; 1981; 65 Suppl 3():43-56. PubMed ID: 6179615
[TBL] [Abstract][Full Text] [Related]
6. In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs.
Yang JZ; Chen W; Borchardt RT
J Pharmacol Exp Ther; 2002 Nov; 303(2):840-8. PubMed ID: 12388671
[TBL] [Abstract][Full Text] [Related]
7. Modern views on pharmacology. II. Drug metabolism.
Crossland J
Practitioner; 1971 Feb; 206(232):293-8. PubMed ID: 5554569
[No Abstract] [Full Text] [Related]
8. [Mechanisms of pharmacokinetic drug interactions. 4: Mechanisms of interaction during biotransformation].
Box A; Heydel E; Fürtig W
Pharmazie; 1984 Apr; 39(4):282-92. PubMed ID: 6377334
[No Abstract] [Full Text] [Related]
9. [Biopharmaceutical aspects of parenteral drug formulations].
Pflegel H
Pharmazie; 1982 Apr; 37(4):307-18. PubMed ID: 7048344
[No Abstract] [Full Text] [Related]
10. Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines.
Brandon EF; Bosch TM; Deenen MJ; Levink R; van der Wal E; van Meerveld JB; Bijl M; Beijnen JH; Schellens JH; Meijerman I
Toxicol Appl Pharmacol; 2006 Feb; 211(1):1-10. PubMed ID: 15975613
[TBL] [Abstract][Full Text] [Related]
11. [Doctor and drugs].
Emmrich R
Z Arztl Fortbild (Jena); 1970 Nov; 64(21):1092-6. PubMed ID: 5505098
[No Abstract] [Full Text] [Related]
12. Rapid in vivo dissolution of ketoprofen: implications on the biopharmaceutics classification system.
Granero GE; Ramachandran C; Amidon GL
Pharmazie; 2006 Aug; 61(8):673-6. PubMed ID: 16964708
[TBL] [Abstract][Full Text] [Related]
13. Liquid chromatography/tandem mass spectrometric quantification with metabolite screening as a strategy to enhance the early drug discovery process.
Tiller PR; Romanyshyn LA
Rapid Commun Mass Spectrom; 2002; 16(12):1225-31. PubMed ID: 12112275
[TBL] [Abstract][Full Text] [Related]
14. Phase I and phase II xenobiotic biotransformation in different inbred strains of rats: study in immobilized perfused hepatocytes.
Hynie S; Kren V; Mráz M; Farghali H
Folia Biol (Praha); 1998; 44(4):127-32. PubMed ID: 10732701
[TBL] [Abstract][Full Text] [Related]
15. [Current therapeutic research and its accomplishments].
Huković S
Med Arh; 1975; 29(5):443-6. PubMed ID: 1219225
[No Abstract] [Full Text] [Related]
16. Moment analysis in vivo and in vitro.
von Hattingberg HM
Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):589-95. PubMed ID: 6513675
[TBL] [Abstract][Full Text] [Related]
17. [Effect of the time of administration of a drug on its pharmacokinetics].
Bruguerolle B
Therapie; 1983; 38(3):223-35. PubMed ID: 6351334
[No Abstract] [Full Text] [Related]
18. Sarcolemmal calcium transport and drug action.
Nayler WG; Mas-Oliva J; Williams AJ
Adv Myocardiol; 1980; 1():77-94. PubMed ID: 6248943
[TBL] [Abstract][Full Text] [Related]
19. [Biopharmaceutics and drug formulation].
Riccieri FM
Ann Ist Super Sanita; 1982; 18(3):541-6. PubMed ID: 7187842
[No Abstract] [Full Text] [Related]
20. In vivo drug-drug interaction studies--a survey of all new molecular entities approved from 1987 to 1997.
Marroum PJ; Uppoor RS; Parmelee T; Ajayi F; Burnett A; Yuan R; Svadjian R; Lesko LJ; Balian JD
Clin Pharmacol Ther; 2000 Sep; 68(3):280-5. PubMed ID: 11014409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
